Zofia Hałabuda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zofia Hałabuda has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Alicja Benecka
Prof. S. T. Dąbrowski Hospital in Puszczykowo S.A., 11 Józefa Ignacego Kraszewskiego Street, 62-040 Puszczykowo, Poland
3 shared publications - Iwona Kawka-Bryk
Medical University of Lublin, Lublin, Poland
3 shared publications - Jakub Majewski
Hospital Murcki Limited Liability Company, Katowice, Poland
3 shared publications - Julia Paczyna
Regional Specialized Hospital No. 4, Bytom, Poland
3 shared publications - Kornelia Rynkiewicz
Medical University of Warsaw, Warsaw, Poland
3 shared publications - Maria JęDryka
Public Health Care Institution in Oława, Baczyńskiego 1, 55-200 Oława, Poland
3 shared publications
Latest Publications
- Open Access
- 28 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(51))
OBESITY, ENDOMETRIOSIS, AND GLP-1 RECEPTOR AGONISTS: A NARRATIVE REVIEW
Endometriosis is a chronic, estrogen-dependent inflammatory disease affecting approximately 10% of women of reproductive age and is one of the leading causes of chronic pelvic pain and infertility. The relationship between obesity and endometriosis remains controversial. Although epidemiological studies indicate that endometriosis is diagnosed less frequently in women with a higher body mass index (BMI), excessive adipose tissue may promote disease progression through hormonal disturbances, chronic inflammation, and altered metabolic activity of adipose tissue. This review summarizes the current evidence regarding the mechanisms linking obesity and endometriosis and discusses the potential role of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in the treatment of this disease. In addition to their well-established efficacy in the management of obesity and type 2 diabetes, GLP-1RAs have been shown to promote weight loss, improve metabolic parameters, and reduce chronic inflammation. Available experimental and observational evidence suggests that these mechanisms may indirectly influence the course of endometriosis by modulating the chronic inflammation and the metabolic disturbances associated with obesity. To date, no randomized clinical trials have evaluated the efficacy of GLP-1 receptor agonists in women with endometriosis, and most of the available evidence is derived from preclinical studies, observational studies, and analyses conducted in patients with polycystic ovary syndrome (PCOS). Current evidence suggests that GLP-1RAs represent a promising area of research; however, their role in the treatment of endometriosis requires confirmation in well-designed clinical trials.
- 28 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (3(51))
Open AccessOBESITY, ENDOMETRIOSIS, AND GLP-1 RECEPTOR AGONISTS: A NARRATIVE REVIEW
Endometriosis is a chronic, estrogen-dependent inflammatory disease affecting approximately 10% of women of reproductive age and is one of the leading causes of chronic pelvic pain and infertility. The relationship between obesity and endometriosis remains controversial. Although epidemiological studies indicate that endometriosis is diagnosed less frequently in women with a higher body mass index (BMI), excessive adipose tissue may promote disease progression through hormonal disturbances, chronic inflammation, and altered metabolic activity of adipose tissue. This review summarizes the current evidence regarding the mechanisms linking obesity and endometriosis and discusses the potential role of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in the treatment of this disease. In addition to their well-established efficacy in the management of obesity and type 2 diabetes, GLP-1RAs have been shown to promote weight loss, improve metabolic parameters, and reduce chronic inflammation. Available experimental and observational evidence suggests that these mechanisms may indirectly influence the course of endometriosis by modulating the chronic inflammation and the metabolic disturbances associated with obesity. To date, no randomized clinical trials have evaluated the efficacy of GLP-1 receptor agonists in women with endometriosis, and most of the available evidence is derived from preclinical studies, observational studies, and analyses conducted in patients with polycystic ovary syndrome (PCOS). Current evidence suggests that GLP-1RAs represent a promising area of research; however, their role in the treatment of endometriosis requires confirmation in well-designed clinical trials.
- Open Access
- 17 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 69
From Monitoring to Prevention: Wearable Technology for Injury Prevention in Sport: A Narrative Review
Background Wearable technologies are used in sport to monitor training load, biomechanics, physiology, and recovery, but their effectiveness in injury prevention remains uncertain. Aim To evaluate evidence on wearables for sports injury prevention using a framework covering measurement validity, injury association, prognostic modelling, implementation, and intervention effectiveness. Material and methods A narrative review of wearables monitoring modifiable injury-related factors was conducted. Findings were organized across five translational levels, from measurement validity to injury reduction, following SANRA recommendations [20]. Results Validity and reliability depend on the device, algorithm, sensor placement, and sporting task. Associations between wearable-derived metrics and injuries are inconsistent and do not support universal risk thresholds. Machine-learning models show promise, but their use is limited by poor external validation, calibration, and methods. Implementation, organizational context, and human decision-making affect practical value. Direct evidence that wearable-guided interventions reduce injuries remains scarce. Conclusions Wearables should be viewed as monitoring and decision-support tools rather than autonomous injury-prevention systems. Evidence is strongest for measurement and weakens toward injury reduction. Future research should prioritize multicentre validation, causal modelling, standardized reporting, and pragmatic trials.
- 17 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 69
Open AccessFrom Monitoring to Prevention: Wearable Technology for Injury Prevention in Sport: A Narrative Review
Background Wearable technologies are used in sport to monitor training load, biomechanics, physiology, and recovery, but their effectiveness in injury prevention remains uncertain. Aim To evaluate evidence on wearables for sports injury prevention using a framework covering measurement validity, injury association, prognostic modelling, implementation, and intervention effectiveness. Material and methods A narrative review of wearables monitoring modifiable injury-related factors was conducted. Findings were organized across five translational levels, from measurement validity to injury reduction, following SANRA recommendations [20]. Results Validity and reliability depend on the device, algorithm, sensor placement, and sporting task. Associations between wearable-derived metrics and injuries are inconsistent and do not support universal risk thresholds. Machine-learning models show promise, but their use is limited by poor external validation, calibration, and methods. Implementation, organizational context, and human decision-making affect practical value. Direct evidence that wearable-guided interventions reduce injuries remains scarce. Conclusions Wearables should be viewed as monitoring and decision-support tools rather than autonomous injury-prevention systems. Evidence is strongest for measurement and weakens toward injury reduction. Future research should prioritize multicentre validation, causal modelling, standardized reporting, and pragmatic trials.
- Open Access
- 2 July 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (3(51))
ADOLESCENT BODY DYSMORPHIC DISORDER IN THE MODERN SOCIAL LANDSCAPE: A REVIEW OF CURRENT LITERATURE
Background and Aim: Body Dysmorphic Disorder (BDD) is a debilitating psychiatric condition that is increasingly affecting adolescents, largely exacerbated by the modern digital and social landscape. The aim of this article is to provide a comprehensive review of the current literature regarding the psychosocial risk factors, severe consequences, and diagnostic screening tools associated with adolescent BDD. Methodology: A narrative review of the current literature was conducted. The analysis synthesized recent studies, clinical guidelines, and theoretical papers focusing on the intersection of adolescent BDD, digital environments, peer dynamics, psychiatric risks, and diagnostic practices. Results: The reviewed literature indicates that social media exposure, peer dynamics, and bullying (including cyberbullying) serve as primary risk factors that trigger and intensify BDD symptoms in youth. The analysis also highlights severe psychosocial threats, demonstrating a concerning correlation between untreated adolescent BDD, self-injurious behaviors, and suicidality. Furthermore, the review identifies and evaluates the most effective, evidence-based screening scales currently recommended for early detection of the disorder. Conclusion: The modern social landscape significantly amplifies the risk and severity of BDD among adolescents. Due to the high risk of severe, life-threatening outcomes, there is an urgent need for heightened clinical awareness and the routine implementation of standardized screening protocols by healthcare professionals and educators to ensure early identification and intervention.
- 2 July 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (3(51))
Open AccessADOLESCENT BODY DYSMORPHIC DISORDER IN THE MODERN SOCIAL LANDSCAPE: A REVIEW OF CURRENT LITERATURE
Background and Aim: Body Dysmorphic Disorder (BDD) is a debilitating psychiatric condition that is increasingly affecting adolescents, largely exacerbated by the modern digital and social landscape. The aim of this article is to provide a comprehensive review of the current literature regarding the psychosocial risk factors, severe consequences, and diagnostic screening tools associated with adolescent BDD. Methodology: A narrative review of the current literature was conducted. The analysis synthesized recent studies, clinical guidelines, and theoretical papers focusing on the intersection of adolescent BDD, digital environments, peer dynamics, psychiatric risks, and diagnostic practices. Results: The reviewed literature indicates that social media exposure, peer dynamics, and bullying (including cyberbullying) serve as primary risk factors that trigger and intensify BDD symptoms in youth. The analysis also highlights severe psychosocial threats, demonstrating a concerning correlation between untreated adolescent BDD, self-injurious behaviors, and suicidality. Furthermore, the review identifies and evaluates the most effective, evidence-based screening scales currently recommended for early detection of the disorder. Conclusion: The modern social landscape significantly amplifies the risk and severity of BDD among adolescents. Due to the high risk of severe, life-threatening outcomes, there is an urgent need for heightened clinical awareness and the routine implementation of standardized screening protocols by healthcare professionals and educators to ensure early identification and intervention.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
DIGITAL COGNITIVE-BEHAVIORAL THERAPY FOR INSOMNIA (dCBT-I) AS A METHOD OF HYPNOTIC MEDICATION REDUCTION USE
Introduction & objective: Insomnia, being an established health problem, has led to the development of various ways of treatment. While Cognitive Behavioral Therapy is a gold standard of insomnia treatment, due to cost and accessibility limitations, pharmacological methods remain widely used. The most commonly used drugs are benzodiazepines and Z-drugs, which, due to their adverse effects and high dependency risk, impose various dangers. One of the “side effects” of insomnia treatment is the development of drug dependence. Well-established methods of combating these issues concern only benzodiazepines, Z-drug medication use reduction protocols are still unavailable. However, considering both these drugs, a slow dose reduction method is believed to be the most effective and safe. The newest research examines the use of digital CBT as a tool for reducing drug dependence. The results are promising, as combining slow dose reduction with digital CBT yields better outcomes than the previous approach. However, there is still limited data on the use of digital CBT in reducing reliance on pharmacological interventions in high-risk patient groups or among patients with high levels of dependency, the development of official protocols is needed. This literature review aims to assess progress in this field of medicine. Review methods: This review is based on a non-systematic review of PubMed articles published between 2008 and 2026. Brief description of state knowledge: In numerous studies, the efficacy of digital CBT is a safe and effective method of insomnia treatment. Concerning previous addiction reduction methods, the only established guidelines are those concerning benzodiazepine dependency, and they involve the method of slow dose reduction. Recent clinical trials suggest that combining digital CBT with dose reduction may be an alternative, demonstrating greater efficacy in treating pharmacological dependence. Summary: Digital CBT-I is not only an alternative to traditional face-to-face CBT for the management of insomnia but may also represent a scalable and clinically relevant strategy for reducing benzodiazepine and Z-drug dependence. Emerging evidence suggests that combining gradual dose reduction with digital CBT-I may enhance deprescribing outcomes compared with tapering alone. However, limited real‑world safety data highlight the need for further research to define better safety and protocols for dependency reduction in patients overusing benzodiazepines and Z-drugs using digital CBT.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
Open AccessDIGITAL COGNITIVE-BEHAVIORAL THERAPY FOR INSOMNIA (dCBT-I) AS A METHOD OF HYPNOTIC MEDICATION REDUCTION USE
Introduction & objective: Insomnia, being an established health problem, has led to the development of various ways of treatment. While Cognitive Behavioral Therapy is a gold standard of insomnia treatment, due to cost and accessibility limitations, pharmacological methods remain widely used. The most commonly used drugs are benzodiazepines and Z-drugs, which, due to their adverse effects and high dependency risk, impose various dangers. One of the “side effects” of insomnia treatment is the development of drug dependence. Well-established methods of combating these issues concern only benzodiazepines, Z-drug medication use reduction protocols are still unavailable. However, considering both these drugs, a slow dose reduction method is believed to be the most effective and safe. The newest research examines the use of digital CBT as a tool for reducing drug dependence. The results are promising, as combining slow dose reduction with digital CBT yields better outcomes than the previous approach. However, there is still limited data on the use of digital CBT in reducing reliance on pharmacological interventions in high-risk patient groups or among patients with high levels of dependency, the development of official protocols is needed. This literature review aims to assess progress in this field of medicine. Review methods: This review is based on a non-systematic review of PubMed articles published between 2008 and 2026. Brief description of state knowledge: In numerous studies, the efficacy of digital CBT is a safe and effective method of insomnia treatment. Concerning previous addiction reduction methods, the only established guidelines are those concerning benzodiazepine dependency, and they involve the method of slow dose reduction. Recent clinical trials suggest that combining digital CBT with dose reduction may be an alternative, demonstrating greater efficacy in treating pharmacological dependence. Summary: Digital CBT-I is not only an alternative to traditional face-to-face CBT for the management of insomnia but may also represent a scalable and clinically relevant strategy for reducing benzodiazepine and Z-drug dependence. Emerging evidence suggests that combining gradual dose reduction with digital CBT-I may enhance deprescribing outcomes compared with tapering alone. However, limited real‑world safety data highlight the need for further research to define better safety and protocols for dependency reduction in patients overusing benzodiazepines and Z-drugs using digital CBT.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
DIGITAL COGNITIVE-BEHAVIORAL THERAPY FOR INSOMNIA: SAFETY, LIMITATIONS, AND PATIENT-SPECIFIC CONTRAINDICATIONS
Introduction & objective: Insomnia is a well-established clinical problem that places a burden on the healthcare system. Due to low accessibility to professional therapists, high costs, and geographical barriers, cognitive-behavioural therapy, which is a first-line treatment for insomnia, is rarely prescribed in clinical practice. The development of digital CBT-I was aimed at overcoming those issues. However, there is still limited data regarding the safety and implementation of dCBT-I in real-life settings. Our aim was to select a specific patient group in which the traditional approach to CBT-I is preferred/advised. Review methods: This review is based on a non-systematic review of PubMed articles published between 2015 and 2026. Brief description of state knowledge: In numerous studies, dCBT-I has been proven to be an effective alternative to face-to-face therapy. It can be delivered in several technological forms and may vary in the level of therapist oversight. Although each form of digital CBT-I is to some extent automated, fully automated platforms raise the greatest concerns regarding safety and patient outcomes. Thus, some research suggests that there are patients for whom face-to-face therapy would be advisable. Summary: Digital CBT‑I with therapist oversight may be particularly important for patients with psychiatric disorders, epilepsy, obstructive sleep apnea, safety‑critical occupations, and older adults; however, limited real‑world safety data highlight the need for further research to better define high‑risk groups and refine clinical guidelines.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
Open AccessDIGITAL COGNITIVE-BEHAVIORAL THERAPY FOR INSOMNIA: SAFETY, LIMITATIONS, AND PATIENT-SPECIFIC CONTRAINDICATIONS
Introduction & objective: Insomnia is a well-established clinical problem that places a burden on the healthcare system. Due to low accessibility to professional therapists, high costs, and geographical barriers, cognitive-behavioural therapy, which is a first-line treatment for insomnia, is rarely prescribed in clinical practice. The development of digital CBT-I was aimed at overcoming those issues. However, there is still limited data regarding the safety and implementation of dCBT-I in real-life settings. Our aim was to select a specific patient group in which the traditional approach to CBT-I is preferred/advised. Review methods: This review is based on a non-systematic review of PubMed articles published between 2015 and 2026. Brief description of state knowledge: In numerous studies, dCBT-I has been proven to be an effective alternative to face-to-face therapy. It can be delivered in several technological forms and may vary in the level of therapist oversight. Although each form of digital CBT-I is to some extent automated, fully automated platforms raise the greatest concerns regarding safety and patient outcomes. Thus, some research suggests that there are patients for whom face-to-face therapy would be advisable. Summary: Digital CBT‑I with therapist oversight may be particularly important for patients with psychiatric disorders, epilepsy, obstructive sleep apnea, safety‑critical occupations, and older adults; however, limited real‑world safety data highlight the need for further research to better define high‑risk groups and refine clinical guidelines.
- Open Access
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
DARIDOREXANT IN THE TREATMENT OF INSOMNIA IN ELDERLY PATIENTS WITH COMORBIDITIES
Introduction and objective: Insomnia is one of the most prevalent sleep disorders in the adult population, thereby new methods of pharmacological treatment ought to be analyzed. Current novelty in insomnia treatment is daridorexant, a representative of the dual orexin receptor antagonist (DORA). Given that, the orexin system becomes overactive with age, explaining sleep of lower quality and quantity observed in older population, it is worth analysing the effect of the dual receptor antagonist (DORA) on the insomnia issue in older adults, and whether it proposes a safer choice among the existing pharmacological possibilities. Review methods: A comprehensive literature review was conducted, analyzing studies from the PubMed database of articles published between 2020 and 2025. Brief description of the state of knowledge: Insomnia treatment is based on both non-pharmacological and pharmacological methods. While among non-pharmacological methods cognitive-behavioral therapy is the one recommended, the choice of proper pharmacotherapy can impose more difficulties. The most commonly used medications, nonbenzodiazepine sedative hypnotics, lead to serious adverse effects and impose a risk of dependency. Daridorexant, a medication of proven efficacy, may propose a safer alternative, and furthermore, a more effective one. Summary: In this review, we decided to analyse the existing literature to present the current state of knowledge on the above-mentioned issue with a perspective of the future of this branch of medicine.
- 6 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
Open AccessDARIDOREXANT IN THE TREATMENT OF INSOMNIA IN ELDERLY PATIENTS WITH COMORBIDITIES
Introduction and objective: Insomnia is one of the most prevalent sleep disorders in the adult population, thereby new methods of pharmacological treatment ought to be analyzed. Current novelty in insomnia treatment is daridorexant, a representative of the dual orexin receptor antagonist (DORA). Given that, the orexin system becomes overactive with age, explaining sleep of lower quality and quantity observed in older population, it is worth analysing the effect of the dual receptor antagonist (DORA) on the insomnia issue in older adults, and whether it proposes a safer choice among the existing pharmacological possibilities. Review methods: A comprehensive literature review was conducted, analyzing studies from the PubMed database of articles published between 2020 and 2025. Brief description of the state of knowledge: Insomnia treatment is based on both non-pharmacological and pharmacological methods. While among non-pharmacological methods cognitive-behavioral therapy is the one recommended, the choice of proper pharmacotherapy can impose more difficulties. The most commonly used medications, nonbenzodiazepine sedative hypnotics, lead to serious adverse effects and impose a risk of dependency. Daridorexant, a medication of proven efficacy, may propose a safer alternative, and furthermore, a more effective one. Summary: In this review, we decided to analyse the existing literature to present the current state of knowledge on the above-mentioned issue with a perspective of the future of this branch of medicine.